GALECTIN THERAPEUTICS INC — Form D

GALECTIN THERAPEUTICS INC of NORCROSS, GA, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-28. The offering totals $12.0M, of which $1.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Jack W CallicuttDirectorNorcross, GA
Kevin D FreemanDirectorNorcross, GA
Gilbert S OmennDirectorNorcross, GA
Harold H ShlevinExecutive OfficerNorcross, GA
Theodore H ZuconniDirectorNorcross, GA
Steven G PrelackDirectorNorcross, GA
Gilbert F AmelioDirectorNorcross, GA
Marc G RubinDirectorNorcross, GA
James C CzirrDirectorNorcross, GA
James C CzirrExecutive OfficerNorcross, GA
John G MauldinDirectorNorcross, GA
Peter G TraberDirectorNorcross, GA
Peter G TraberExecutive OfficerNorcross, GA
Jack W CallicuttExecutive OfficerNorcross, GA
Arthur R GreenbergDirectorNorcross, GA
Anthony D SquegliaExecutive OfficerNewton, MA
Maureen D FoleyExecutive OfficerNewton, MA
Theodore D ZucconiDirectorNewton, MA
Theodore D ZucconiExecutive OfficerNewton, MA
Peter D TraberDirectorNewton, MA
S. Colin NeillDirectorNewton, MA
Steven F PrelackDirectorNewton, MA
Jerald F RomeDirector7 Wells Avenue, MA
Anatole C KlyosovExecutive OfficerNewton, MA
Eliezer C ZomerExecutive OfficerNewton, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2017-01-06D$10.0M$3.0M
2015-12-21D
2011-01-12D$2.3M

More